case report | Q2782326 |
scholarly article | Q13442814 |
P2093 | author name string | Don C Rockey | |
Andrew D Schreiner | |||
Amanda N Overstreet | |||
Caroline Stokes Osborne | |||
P2860 | cites work | Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth) | Q24616893 |
Drug-induced liver injury in obesity | Q26828462 | ||
Nonalcoholic fatty liver disease: a systematic review | Q28263139 | ||
Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant | Q34102747 | ||
Seizure and coma following Kratom (Mitragynina speciosa Korth) exposure | Q34111502 | ||
Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa) | Q34181061 | ||
Criteria of drug-induced liver disorders. Report of an international consensus meeting | Q34271897 | ||
Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries | Q34504233 | ||
Notes from the Field: Kratom (Mitragyna speciosa) Exposures Reported to Poison Centers - United States, 2010-2015. | Q34535611 | ||
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network | Q34943114 | ||
Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug-Induced Liver Injury Network (DILIN). | Q35009149 | ||
Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method | Q35644300 | ||
Drug-Induced Liver Injury: Pattern Recognition and Future Directions | Q36412863 | ||
Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct | Q36799781 | ||
Acute Cytomegalovirus Hepatitis in an Immunocompetent Host as a Reason for Upper Right Abdominal Pain | Q37057099 | ||
Overview of the diagnosis of cytomegalovirus infection | Q37062282 | ||
Is Kratom the New 'Legal High' on the Block?: The Case of an Emerging Opioid Receptor Agonist with Substance Abuse Potential | Q42058872 | ||
Inhibitory effect of mitragynine on human cytochrome P450 enzyme activities | Q42934962 | ||
Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine | Q45759119 | ||
The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease | Q50117379 | ||
Legal highs on the Internet. | Q52295945 | ||
Drug induced liver injury with analysis of alternative causes as confounding variables. | Q54243795 | ||
Kratom: a dangerous player in the opioid crisis. | Q55399670 | ||
Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge | Q72576810 | ||
Cholestatic hepatitis from prolonged kratom use: a case report | Q86042400 | ||
P921 | main subject | opioid | Q427523 |
P304 | page(s) | 2324709619826167 | |
P577 | publication date | 2019-01-01 | |
P1433 | published in | Journal of investigative medicine high impact case reports | Q27725587 |
P1476 | title | Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic | |
P478 | volume | 7 |
Q90115925 | Kratom-Induced Cholestatic Liver Injury Mimicking Anti-Mitochondrial Antibody-Negative Primary Biliary Cholangitis: A Case Report and Review of Literature | cites work | P2860 |
Search more.